Foghorn Therapeutics Inc. (FHTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...
AppLovin, Silvercorp Metals and Powell Industries have been selected as the top picks with a high net income ratio.
As we enter 2025, many growth stocks are trading at high valuations and could be running out of room to rise in the near term ...
Growth stocks are equity shares likely to outperform their peers and the broader market. Here's a list of stocks that contain investment potential to beef up your portfolio.
Needham analyst Ami Fadia maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of $133.00.Don't ...
Kenneth Goldman, an analyst from J.P. Morgan, maintained the Buy rating on Kroger Company (KR – Research Report). The associated price target ...
Dell stock is trading at a reasonable valuation of 15 times this year's earnings estimate. It also offers a dividend yield of ...